The Journal of Organic Chemistry
Article
NMR (DMSO-d6, 500.13 MHz) δ 8.39 (s, 1 H), 8.03 (d, J = 1.0 Hz, 1
H), 7.91−7.92 (m, 3 H), 7.74 (d, J = 4.0 Hz, 2 H), 7.67 (d, J = 3.5 Hz,
1 H), 7.55−7.61 (m, 9 H), 7.50−7.52 (m, 4 H), 7.44 (d, J = 7.0 Hz, 2
H), 7.20−7.26 (m, 4 H), 7.13−7.17 (m, 2 H), 6.70 (d, J = 8.0 Hz, 1
H), 4.04−4.06 (m, 2 H), 3.58 (s, 2 H), 2.27−2.28 (m, 4 H), 0.99 (t, J
= 7.0 Hz, 3 H), 0.77 (t, J = 7.0 Hz, 3 H), 0.32−0.34 (m, 6 H); 13C
NMR (CDCl3+TFA, 125.77 MHz) δ 154.0, 153.1, 148.8, 145.8, 144.9,
142.6, 141.4, 140.9, 136.6, 135.8, 134.1, 131.7, 131.5, 131.3, 131.1,
131.0, 130.7, 130.6, 130.5, 130.3, 130.22, 130.16, 130.1, 130.0, 129.4,
129.3, 129.2, 128.7, 128.4, 127.3, 127.2, 127.0, 126.0, 125.4, 125.31,
125.25, 124.9, 121.6, 121.4, 120.8, 116.1, 57.5, 42.1, 42.0, 32.2, 15.1,
14.8, 8.0; HRMS (FAB) m/z calcd for C63H50N5O2S2 (M − H)
972.3411, found 972.3414; m/z calcd for C63H51N5NaO2S2 (M + Na)
996.3387, found 996.3378.
57.0, 32.4, 8.0; HRMS (ESI) m/z calcd for C32H28BrN2 (M + H)
521.1415, found 521.1426.
2-(7-Bromo-9,9-diethyl-9H-fluoren-2-yl)-1-ethyl-4,5-diphenyl-1H-
imidazole (9). Compound 9 was synthesized following the procedure
as described for the synthesis of 6a, by using 8 (52 g, 1 mmol) and
bromoethane (0.16 g, 2 mmol): light-yellow solid; yield 0.47 g, 78%;
1
mp 183−185 °C; H NMR (CDCl3, 500.13 MHz) δ 7.79 (d, J = 8.0
Hz, 1 H), 7.67−7.70 (m, 2 H), 7.60−7.62 (m, 1 H), 7.43−7.54 (m, 9
H), 7.21 (t, J = 7.5 Hz, 2 H), 7.14 (tt, J = 7.5 Hz, 1.5 Hz, 1 H), 3.96 (q,
J = 7.0 Hz, 2 H), 2.02−2.11 (m, 4 H), 1.01 (t, J = 7.0 Hz, 3 H), 0.35 (t,
J = 7.5 Hz, 6 H); 13C NMR (CDCl3, 125.77 MHz) δ 152.5, 149.8,
147.7, 141.1, 140.0, 137.9, 134.6, 131.6, 131.1, 130.5, 130.2, 129.6,
129.1, 128.7, 128.3, 128.1, 126.9, 126.4, 126.3, 123.8, 121.6, 121.4,
119.9, 56.7, 39.8, 32.8, 16.1, 8.6; HRMS (ESI) m/z calcd for
C34H32BrN2 (M + H) 549.1729, found 549.1739.
(E)-3-(5-(5,7-Bis(4,5-bis(9,9-diethyl-9H-fluoren-2-yl)-1-ethyl-1H-
imidazol-2-yl)-9,9-diethyl-9H-fluoren-2-yl)thiophene-2-yl)-2-cya-
noacrylic Acid (IF5). Compound IF5 was obtained from 7c by
following a procedure described above for IF3: yellow solid; yield 0.30
5-(9,9-Diethyl-7-(1-ethyl-4,5-diphenyl-1H-imidazol-2-yl)-9H-fluo-
ren-2-yl)thiophene-2-carbaldehyde (10a). Compound 10a was
obtained by following the procedure as described for the synthesis
of 7a by using 9 in place of 6a: yellow solid; yield 0.18 g, 63%; mp
214−216 °C; IR (KBr, cm−1) 1655 (νCO); 1H NMR (CDCl3, 500.13
MHz) δ 9.90 (s, 1 H), 7.85 (d, J = 8.0 Hz, 1 H), 7.76−7.80 (m, 2 H),
7.70−7.73 (m, 3 H), 7.66 (d, J = 1.5 Hz, 1 H), 7.43−7.54 (m, 8 H),
7.22 (t, J = 7.5 Hz, 2 H), 7.15 (tt, J = 7.5 Hz, 1.0 Hz, 1 H), 3.99 (q, J =
7.0 Hz, 2 H), 2.12−2.16 (m, 4 H), 1.03 (t, J = 7.0 Hz, 3 H), 0.40 (t, J =
7.5 Hz, 6 H); 13C NMR (CDCl3, 125.77 MHz) δ 182.8, 155.0, 151.4,
150.7, 147.6, 142.5, 142.1, 141.3, 137.8, 137.6, 134.3, 132.3, 131.3,
131.1, 130.3, 129.7, 129.1, 128.8, 128.3, 128.1, 127.0, 126.4, 125.8,
124.04, 123.96, 120.8, 120.7, 120.3, 56.7, 39.9, 32.8, 16.1, 8.6; HRMS
(ESI) m/z calcd for C39H35N2OS (M + H) 579.2465, found 579.2472.
5′-(9,9-Diethyl-7-(1-ethyl-4,5-diphenyl-1H-imidazol-2-yl)-9H-flu-
oren-2-yl)-2,2′-bithiophene-5-carbaldehyde (10b). Compound 10b
was obtained by following the procedure as described for the synthesis
of 7a by using 9 and (5′-(1,3-dioxolan-2-yl)-2,2′-bithiophene-5-
yl)tributylstannane: light-brown solid; yield 0.22 g, 68%; mp 160−
1
g, 84%; mp >300 °C; IR (KBr, cm−1) 2207 (νCN), 1699, 1582; H
NMR (DMSO-d6, 500.13 MHz) δ 8.02−8.08 (m, 2 H), 7.90−7.98 (m,
5 H), 7.82−7.84 (m, 1 H), 7.70−7.76 (m, 5 H), 7.55−7.65 (m, 7 H),
7.49−7.51 (m, 2 H), 7.40 (s, 6 H), 7.21−7.34 (m, 7 H), 6.88−6.96
(m, 1 H), 4.15 (s, 2 H), 3.62−3.66 (m, 2 H), 2.27−2.36 (m, 4 H),
2.06−2.15 (m, 8 H), 1.82−1.91 (m, 4 H), 1.65−1.75 (m, 4 H), 1.05 (t,
J = 7.0 Hz, 3 H), 0.85 (t, J = 7.0 Hz, 3 H), 0.23−0.37 (m, 18 H),
0.13−0.18 (m, 12 H); 13C NMR (DMSO-d6 + TFA, 125.77 MHz) δ
163.5, 152.7, 152.4, 152.3, 151.8, 150.6, 150.5, 149.8, 149.74, 149.70,
149.52, 149.49, 146.4, 143.4, 143.2, 142.8, 142.7, 142.2, 142.1, 141.1,
140.8, 140.6, 139.8, 138.1, 135.3, 133.9, 131.5, 131.04, 130.97, 130.9,
130.7, 130.6, 130.0, 129.7, 128.2, 127.9, 127.2, 127.0, 126.6, 126.3,
126.0, 125.5, 125.3, 125.2, 124.7, 124.6, 122.9, 122.8, 122.5, 122.2,
121.7, 120.8, 120.4, 120.3, 120.19, 120.15, 120.1, 120.0, 118.0, 116.9,
56.0, 55.9, 55.59, 55.56, 41.4, 41.3, 31.7, 31.5, 31.2, 14.3, 14.2, 8.4,
8.08, 8.05, 7.9, 7.8; HRMS (FAB) m/z calcd for C103H96N5O2S (M −
H) 1466.7279, found 1466.7286.
1
162 °C; IR (KBr, cm−1) 1653 (νCO); H NMR (CDCl3, 500.13
MHz) δ 9.88 (s, 1 H), 7.83 (d, J = 7.5 Hz, 1 H), 7.77 (d, J = 8.0 Hz, 1
H), 7.69−7.73 (m, 3 H), 7.64 (dd, J = 8.0 Hz, 1.5 Hz, 1 H), 7.58 (d, J
= 1.5 Hz, 1 H), 7.54−7.55 (m, 2 H), 7.48−7.51 (m, 3 H), 7.44−7.46
(m, 2 H), 7.37 (q, J = 4.0 Hz, 2 H), 7.29 (d, J = 4.0 Hz, 1 H), 7.21 (t, J
= 7.5 Hz, 2 H), 7.14 (tt, J = 7.5 Hz, 1.5 Hz, 1 H), 3.98 (q, J = 7.0 Hz, 2
H), 2.13 (q, J = 7.5 Hz, 4 H), 1.03 (t, J = 7.0 Hz, 3 H), 0.40 (t, J = 7.5
Hz, 6 H); 13C NMR (CDCl3, 125.77 MHz) δ 182.4, 151.2, 150.3,
147.6, 147.1, 146.6, 141.4, 141.3, 141.2, 137.7, 137.4, 134.7, 134.5,
132.5, 131.4, 131.0, 130.2, 129.5, 129.0, 128.6, 128.1, 128.0, 127.1,
126.7, 126.1, 124.9, 124.0, 123.9, 123.6, 120.5, 120.0, 119.9, 56.4, 39.7,
32.7, 16.0, 8.5; HRMS (ESI) m/z calcd for C43H37N2OS2 (M + H)
661.2342, found 661.2354.
(E)-3-(5′-(5,7-Bis(4,5-bis(9,9-diethyl-9H-fluoren-2-yl)-1-ethyl-1H-
imidazol-2-yl)-9,9-diethyl-9H-fluoren-2-yl)-2,2′-bithiophene-5-yl)-2-
cyanoacrylic Acid (IF6). Compound IF6 was obtained from 7d by
following a procedure described above for IF3: orange solid; yield 0.32
1
g, 85%; mp >300 °C; IR (KBr, cm−1) 2205 (νCN), 1699, 1585; H
NMR (DMSO-d6, 500.13 MHz) δ 8.38 (s, 1 H), 8.03−8.08 (m, 2 H),
7.90−7.98 (m, 6 H), 7.81 (d, J = 9.5 Hz, 1 H), 7.70−7.76 (m, 5 H),
7.66−7.68 (m, 4 H), 7.55−7.63 (m, 4 H), 7.49−7.51 (m, 2 H), 7.39−
7.41 (m, 6 H), 7.33 (t, J = 7.5 Hz, 2 H), 7.25−7.30 (m, 4 H), 6.90 (d, J
= 8.0 Hz, 1 H), 4.14−4.16 (m, 2 H), 3.66 (s, 2 H), 2.31−2.36 (m, 4
H), 2.04−2.14 (m, 8 H), 1.82−1.89 (m, 4 H), 1.65−1.75 (m, 4 H),
1.06 (t, J = 7.5 Hz, 3 H), 0.85 (t, J = 7.0 Hz, 3 H), 0.30−0.38 (m, 18
H), 0.11−0.18 (m, 12 H); 13C NMR (DMSO-d6 + TFA, 125.77 MHz)
δ 163.5, 152.6, 152.4, 150.6, 150.5, 149.9, 149.7, 149.5, 146.2, 145.2,
144.5, 143.4, 143.2, 142.7, 142.2, 142.1, 141.2, 140.7, 139.8, 137.0,
135.1, 134.5, 134.2, 131.4, 131.1, 131.0, 130.7, 130.0, 129.7, 128.4,
128.2, 127.8, 127.2, 127.0, 126.6, 126.4, 126.3, 125.9, 125.4, 125.3,
124.9, 124.7, 122.8, 122.2, 121.7, 120.8, 120.6, 120.3, 120.1, 120.0,
116.5, 116.4, 56.8, 56.0, 55.9, 55.6, 41.3, 31.7, 31.5, 31.2, 14.3, 13.5,
8.4, 8.0, 7.9; HRMS (FAB) m/z calcd for C107H98N5O2S2 (M − H)
1548.7156, found 1548.7162.
(E)-2-Cyano-3-(5-(9,9-diethyl-7-(1-ethyl-4,5-diphenyl-1H-imida-
zol-2-yl)-9H-fluoren-2-yl)thiophene-2-yl)acrylic acid (IF1). Com-
pound IF1 was obtained from 10a by following a procedure described
for IF3: yellow solid; yield 0.13 g, 82%; mp 204−206 °C; IR (KBr,
1
cm−1) 2206 (νCN), 1698, 1582; H NMR (DMSO-d6, 500.13 MHz)
δ 8.51 (s, 1 H), 8.02−8.06 (m, 3 H), 7.90−7.93 (m, 2 H), 7.82−7.85
(m, 2 H), 7.74 (dd, J = 7.5 Hz, 1.5 Hz, 1 H), 7.54−7.59 (m, 3 H),
7.48−7.50 (m, 2 H), 7.42−7.43 (m, 2 H), 7.21 (t, J = 7.5 Hz, 2 H),
7.13 (tt, J = 7.0 Hz, 1.5 Hz, 1 H), 3.96 (q, J = 7.0 Hz, 2 H), 2.18 (q, J =
7.5 Hz, 4 H), 0.95 (t, J = 7.0 Hz, 3 H), 0.30 (t, J = 7.5 Hz, 6 H); 13C
NMR (DMSO-d6 + TFA, 125.77 MHz) δ 163.5, 152.9, 151.4, 150.7,
146.5, 144.3, 143.8, 141.0, 140.9, 134.7, 132.7, 130.9, 130.5, 130.2,
129.5, 129.4, 129.2, 129.0, 128.7, 128.0, 127.6, 126.7, 126.2, 125.9,
125.5, 124.6, 121.8, 121.6, 121.0, 120.6, 116.4, 56.5, 41.2, 31.5, 14.3,
8.2; HRMS (FAB) m/z calcd for C42H34N3O2S (M−H) 644.2377,
found 644.2389; m/z calcd for C42H35N3NaO2S (M + Na) 668.2353,
found 668.2366.
2-(7-Bromo-9,9-diethyl-9H-fluoren-2-yl)-4,5-diphenyl-1H-imida-
zole (8). Compound 8 was synthesized following the general
procedure as described for the synthesis of 5a and 5b by using 7-
bromo-9,9-diethyl-9H-fluorene-2-carbaldehyde (2b) (0.66 g, 2 mmol)
and benzil (0.42 g, 2 mmol): cream-colored solid; yield 0.78 g, 75%;
1
mp >300 °C; H NMR (acetone-d6, 500.13 MHz) δ 11.79 (s, 1 H),
8.21 (s, 1 H), 8.19 (dd, J = 8.0 Hz, 1.5 Hz, 1 H), 7.92 (d, J = 8.0 Hz, 1
H), 7.81 (d, J = 8.0 Hz, 1 H), 7.69−7.70 (m, 2 H), 7.66 (d, J = 1.5 Hz,
1 H), 7.54−7.57 (m, 3 H), 7.44 (t, J = 7.5 Hz, 2 H), 7.36−7.39 (m, 1
H), 7.32 (t, J = 7.5 Hz, 2 H), 7.24 (t, J = 7.5 Hz, 1 H), 2.16 (q, J = 7.5
Hz, 4 H), 0.33 (t, J = 7.5 Hz, 6 H); 13C NMR (CDCl3+TFA, 125.77
MHz) δ 152.9, 151.5, 145.6, 144.8, 144.7, 138.5, 130.7, 130.3, 129.5,
129.3, 128.1, 126.6, 126.0, 125.8, 123.4, 122.1, 121.2, 121.0, 119.9,
(E)-2-Cyano-3-(5′-(9,9-diethyl-7-(1-ethyl-4,5-diphenyl-1H-imida-
zol-2-yl)-9H-fluoren-2-yl)-2,2′-bithiophene-5-yl)acrylic Acid (IF2).
Compound IF2 was obtained from 10b by following a procedure
described for IF3: orange solid; yield 0.15 g, 86%; mp 168−170 °C; IR
1
(KBr, cm−1) 2203 (νCN), 1708, 1585; H NMR (DMSO-d6, 500.13
MHz) δ 8.51 (s, 1 H), 7.96−8.03 (m, 3 H), 7.88 (s, 1 H), 7.76−7.80
3170
dx.doi.org/10.1021/jo500330r | J. Org. Chem. 2014, 79, 3159−3172